Abstract:Objective To observe the expression of Her-2/neu protein and androgen receptor (AR) in human prostate cancer and to evaluate their significances in the progression of prostate cancer. Methods The Her-2/neu protein and AR immunohistochemical stain were carried out in human prostate tissue microarray that consisted of prostate cancer (107 cases) and benign prostate tissue (42 cases). The prostate cancer cases were divided into 4 groups: group one (Gleason score 6),group two (Gleasonscore 7), group three (Gleasonscore 8) and group four (Gleasonscore 9) according to the Gleason score. The immunostains immunohistochemical stain were interpreted in two aspects of the staining intensity and the percentage of positive cells. The significance and relationships between the expression of Her-2/neu protein and AR in prostate cancer and benign prostate tissue (BPT) and the grouping of different Gleason scores of prostate cancer were then evaluated. Results The positive expression rate of Her-2/neu protein was significantly higher in prostate cancer tissue than in BPT [43.9%(47/107) vs. 14.3%(6/42), x2=11.562, P=0.009], and the positive expression intensity of Her-2/neu immunoreactivity was also higher (x2= 11.764, P=0.008). There were significant differences in positive expression intensity of Her-2/neu immunoreactivity among the different Gleason scores groups (x2 = 20. 512, P = 0. 015), and the expression intensity was significantly positively correlated with Gleason scores ( r= 0. 269, P = 0. 005). There was significant difference in AR immunoreactivity between in prostate cancer (67 %, 72/107) and in BPT (50 %, 21/42, x2 =3. 843, P=0. 050). Among prostate cancer cases, the positive expression intensity of AR was not significantly different among groups 1 through 4 (x2 = 4. 318, P = 0. 229), and was not significantly correlated with Gleason scores ( r = - 0. 065, P = 0. 505 ). Moreover, the positive expression intensity of Her-2/neu protein was not significantly correlated with that of AR (r = -0. 115, P=0. 237). Conclusions Overexpression of Her-2/neu protein in human prostate cancer tissue suggests that Her-2/neu may have some role in prostate tumorigenesis. Her-2/neu protein expression is positively correlated with Gleason score in prostate cancer, which suggests that Her-2/neu may be a potential prognostic predictor of prostate cancer.

Proportion of Intermediate Epithelial Cells and Human Prostate Cancer

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells

The Different Genetic Alterations Between Western and Chinese Prostate Cancers and the Underlying Mechanisms.

Mucinous Prostate Cancer Shows Similar Prognosis To Typical Prostate Acinar Carcinoma: A Large Population-Based And Propensity Score-Matched Study

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

Expression and its significance of Her-2/neu protein and androgen receptor in human prostate cancer

Correlation Between Molecular Biomarkers and Risk Factors for the Clinical Progression of Benign Prostatic Hyperplasia Using Tissue Micro Array Immuno Staining

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].

Relationship between loss of 53BP1 expression and clinical pathology in prostate adenocarcinoma

The expressions and clinical significances of AR in prostate carcinoma

[Cell Apoptosis and Proliferation in the Transition and Peripheral Zones in Human Prostate].

Clinical Implications of Peripheral CD+3CD+69 T-Cell And CD+8CD+28 T-Cell Proportions in Patients Prior to Radical Prostatectomy

Apoptosis Profiles in Benign Prostatic Hyperplasia: Close Associations of Cell Kinetics with Percent Area Density of Histologic Composition.

[Correlation Between Integrin Subunits Alpha5 and Beta1 Expressions in Prostate Cancer and Its Clinical Implication].

Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer

Different Biological Characteristics of Different Prostatic Zonal Primary Stromal Cells and Cancer Associated Stromal Cells,as Well As Their Different Effects on Prostate Cancer Cell Line C4-2B

Distribution and Prognostic Significance of Estrogen Receptors Expression in Prostate Cancer

Ductal Adenocarcinoma Of The Prostate: Immunohistochemical Findings And Clinical Significance

Differences in Phenotype and Gene Expression of Prostate Stromal Cells from Patients of Varying Ages and Their Influence on Tumour Formation by Prostate Epithelial Cells